Synapse - Mark Kris

Results (872)

Serpins promote cancer cell survival and vascular co-option in brain metastasis

Journal Article

Valiente, M.; Obenauf, A. C.; Jin, X.; Chen, Q.; Zhang, X. H. F.; Lee, D. J.; Chaft, J. E.; Kris, M. G.; Huse, J. T.; Brogi, E.; more...
Cell (2014)

Fulltext@MSK | Save

Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing

Journal Article

Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
Annals of Oncology (2014)

Fulltext@MSK | Save

Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: Proposal for the use of major pathological response as a surrogate endpoint

Journal Article

Hellmann, M. D.; Chaft, J. E.; William, W. N.; Rusch, V.; Pisters, K. M. W.; Kalhor, N.; Pataer, A.; Travis, W. D.; Swisher, S. G.; Kris, M. G.
Lancet Oncology (2014)

Fulltext@MSK | Save

Comparison of the characteristics and clinical course of 677 patients with metastatic lung cancers with mutations in KRAS codons 12 and 13

Meeting Abstract

Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S. L.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor (EGFR) T790M mutations

Meeting Abstract

Riely, G. J.; Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Ladanyi, M.; Kris, M. G.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Patterns of metastasis and survival in patients with PI3K pathway-driven stage IV squamous cell lung cancers (SQCLC)

Meeting Abstract

Paik, P. K.; Moreira, A. L.; Wang, L.; Won, H. H.; Hasanovic, A.; Rekhtman, N.; Sima, C. S.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Incidence, characteristics, and survival of patients with EGFR-mutant lung cancers with EGFR T790M at diagnosis identified in the lung cancer mutation consortium (LCMC)

Meeting Abstract

Kris, M. G.; Oxnard, G. R.; Johnson, B. E.; Berry, L. D.; Chen, H.; Kwiatkowski, D. J.; Iafrate, A. J.; Wistuba, I. I.; Franklin, W. A.; Aisner, D.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Feasibility of long-term patient reporting of toxicities from home via the internet during routine chemotherapy

Meeting Abstract

Judson, T. J.; Bennett, A. V.; Rogak, L. J.; Sit, L.; Barz, A.; Kris, M. G.; Hudis, C.; Scher, H. I.; Sabbatini, P.; Schrag, D.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

A multicenter effort to identify driver mutations and employ targeted therapy in patients with lung adenocarcinomas: The Lung Cancer Mutation Consortium (LCMC)

Meeting Abstract

Johnson, B. E.; Kris, M. G.; Berry, L. D.; Kwiatkowski, D. J.; Iafrate, A. J.; Varella-Garcia, M.; Wistuba, I. I.; Franklin, W. A.; Ladanyi, M.; Su, P. F.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Screening for RET and ROS1 fusions in an enriched cohort of pan-negative never-smokers with advanced lung adenocarcinomas to identify patients for treatment in targeted therapy trials

Meeting Abstract

Drilon, A. E. D.; Wang, L.; Hasanovic, A.; Joubert, P.; Kris, M. G.; Riely, G. J.; Ladanyi, M.; Rizvi, N. A.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save